Condition

Neurofibromatosis 1 (1)

Plexiform Neurofibroma (PN) (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

AstraZeneca (1)

Collaborator

Merck Sharp & Dohme LLC (1)

Intervention

placebo (1)

selumetinib (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

plexiform neurofibroma (pn)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Neurofibromatosis 1, Plexiform Neurofibroma (PN) Trial in Worldwide (Selumetinib, Placebo)

Recruiting

Neurofibromatosis 1
Plexiform Neurofibroma (PN)

Selumetinib
Placebo

Gainesville, Florida
+40 more

Jan 16, 2023